Vitalte Lifesciences v. Bonds Therapeutics: Trocar Patent Case Settled in 165 Days
Vitalte Lifesciences filed a patent infringement action against Bonds Therapeutics in the Northern District of Ohio, asserting US11406806B2 covering an atraumatic trocar apparatus, system and kit. The case resolved in just 165 days after the parties reported a settlement to the court.
Trocar patent dispute resolves swiftly via settlement in Ohio federal court
On 28 April 2023, Vitalte Lifesciences, Inc. filed a patent infringement action against Bonds Therapeutics, LLC in the United States District Court for the Northern District of Ohio, before Judge James S. Gwin. The complaint centred on US11406806B2, a patent directed to an atraumatic trocar apparatus, system and kit — a surgical access device category with direct relevance to minimally invasive procedure markets.
The recorded Basis of Termination is 'Case Settled.' The docket order states that, upon representation by counsel that the matter had been settled, the court marked the case 'settled and dismissed with prejudice,' retained continuing jurisdiction to resolve any disputes concerning memorialization of the settlement agreement, and invited the parties to file any subsequent order setting forth different terms and conditions. The specific commercial terms of the settlement are not disclosed in the available public record.
Resolution in 165 days is notably swift for a district-level patent infringement case, suggesting the parties reached an accommodation before significant pre-trial motion practice or claim construction proceedings. What drove that speed — whether licensing economics, a clearance concern, or product-stage considerations — is not apparent from the public record. The court's express retention of jurisdiction under Kokkonen indicates that settlement memorialization may still have been in progress at the time of dismissal.
See Complete Case & Patent Analysis →Filing to Case Settled in 165 days
165 days from filing to close — notably rapid resolution for a district-level patent infringement action
US11406806B2 — Atraumatic Trocar Apparatus, System and Kit
Any company developing, sourcing, or commercialising atraumatic trocar apparatus, systems, or kits — or adjacent minimally invasive surgical access devices — should treat US11406806B2 as a live FTO consideration. The patent has been actively asserted and survived to a private settlement. R&D and regulatory teams at medical device firms entering or expanding in the laparoscopic access segment should prioritise claim-by-claim analysis before product launch or distribution agreements are finalised.
Official order — verbatim text
The court's order reflects a standard settlement-triggered dismissal: upon counsel's representation that the matter had resolved, the docket was marked 'settled and dismissed with prejudice.' The express retention of jurisdiction under Kokkonen suggests the parties had not yet finalised a written settlement agreement at the time of the order, with the court positioned to enforce any subsequently memorialised terms. No merits finding on infringement or validity of US11406806B2 was made.
Case settled: what the agreed resolution means for both parties
Settlement with prejudice and retained court jurisdiction
The court entered a dismissal with prejudice upon the parties' joint representation that the case had settled. Dismissal with prejudice bars Vitalte from re-filing the same infringement claims against Bonds Therapeutics on US11406806B2. The court expressly retained continuing jurisdiction under Kokkonen v. Guardian Life Ins. Co. to resolve any disputes over the settlement's memorialization, indicating a formal written agreement was anticipated.
Dismissed with prejudiceVitalte obtains closure; underlying patent remains enforceable
For Vitalte Lifesciences, the settlement closes the dispute without a court ruling on the merits of US11406806B2. The patent itself is unaffected by the settlement and remains in force. Whether the resolution involved any licensing arrangement, royalty, design-around acknowledgment, or other commercial term is not disclosed in the available public record.
Patent survives; terms undisclosedBonds Therapeutics exits litigation without adverse merits ruling
Bonds Therapeutics resolves the infringement claim without a court adjudication of liability. The dismissal with prejudice means Vitalte cannot reassert these specific claims against Bonds Therapeutics in future litigation. What obligations, if any, Bonds Therapeutics assumed as part of the settlement are not disclosed in the available public record.
No merits adjudicationTrocar IP landscape: rapid settlement signals active enforcement posture
A 165-day resolution without significant pre-trial skirmishing suggests Vitalte is willing to pursue and promptly settle patent infringement claims in the atraumatic trocar space. Competitors and product developers working with surgical access device technology should monitor US11406806B2 and any related Vitalte portfolio patents for continued enforcement activity. The undisclosed settlement terms mean no public licensing benchmark has been established.
Active enforcement signalFull party and counsel information
| Role | Name | Type | Detail |
|---|---|---|---|
| Plaintiff | Vitalte Lifesciences, Inc. | Company | /Search in Eureka ↗ |
| Defendant | Bonds Therapeutics, LLC | Company | /Search in Eureka ↗ |
| Plaintiff counsel | Brandon D. Cox | Attorney | Counsel for Vitalte Lifesciences, Inc.Search in Eureka ↗ |
| Plaintiff counsel | Charles J. Andres | Attorney | Counsel for Vitalte Lifesciences, Inc.Search in Eureka ↗ |
| Plaintiff counsel | Elana B. Araj | Attorney | Counsel for Vitalte Lifesciences, Inc.Search in Eureka ↗ |
| Plaintiff counsel | Scott J. Bornstein | Attorney | Counsel for Vitalte Lifesciences, Inc.Search in Eureka ↗ |
| Plaintiff law firm | Greenberg Traurig LLP | Law Firm | Representing Vitalte Lifesciences, Inc.Search in Eureka ↗ |
| Plaintiff law firm | Greenberg Traurig - New York | Law Firm | Representing Vitalte Lifesciences, Inc.Search in Eureka ↗ |
| Plaintiff law firm | Greenberg Traurig - Washington | Law Firm | Representing Vitalte Lifesciences, Inc.Search in Eureka ↗ |
| Defendant counsel | Philip R. Bautista | Attorney | Counsel for Bonds Therapeutics, LLCSearch in Eureka ↗ |
| Defendant counsel | Ryan O. White | Attorney | Counsel for Bonds Therapeutics, LLCSearch in Eureka ↗ |
| Defendant law firm | Taft, Stettinius & Hollister LLP (ClevelAnd) | Law Firm | Representing Bonds Therapeutics, LLCSearch in Eureka ↗ |
| Defendant law firm | Taft, Stettinius & Hollister LLP (Indianapolis) | Law Firm | Representing Bonds Therapeutics, LLCSearch in Eureka ↗ |
| Presiding judge | Judge James S. Gwin | Judge | Ohio Northern District CourtSearch in Eureka ↗ |
R&D signals in the atraumatic trocar and surgical access space
Forward-looking patent and innovation intelligence derived from the Vitalte v. Bonds Therapeutics dispute and the broader atraumatic trocar technology landscape.
Vitalte Lifesciences' trocar patent family and filing activity
US11406806B2 is the asserted patent, but Vitalte's broader portfolio around atraumatic trocar design warrants monitoring. Continuation and continuation-in-part filings can extend claim coverage into adjacent product configurations. Mapping the full family around application US15/901821 reveals the boundaries of Vitalte's IP perimeter in surgical access.
Portfolio mappingFiling trends in atraumatic and low-trauma trocar design
The atraumatic trocar segment is an active area of innovation within minimally invasive surgery. Patent filing trends around trocar tip geometry, sheath design, and tissue-sparing insertion mechanisms can reveal where the technology is headed and which assignees are building competitive IP positions ahead of the next generation of laparoscopic access tools.
Filing trend watchBonds Therapeutics' IP position in surgical device space
Bonds Therapeutics was named as a defendant in a trocar infringement action, suggesting commercial activity in the surgical access device market. Understanding its own patent holdings — or absence thereof — in this space helps competitors and potential partners assess its technical differentiation strategy and vulnerability to further IP challenges.
Defendant IP profileDesign-around and adjacent innovation near US11406806B2
Where Vitalte's claims carve out specific trocar apparatus configurations, adjacent design spaces — alternative tip geometries, different sheath or seal mechanisms, or combined instrument-access systems — may represent patentable white space. R&D teams can use citation mapping around US11406806B2 to identify claim gaps and design-around pathways that avoid the enforced IP.
White space analysisSimilar patent infringement cases in surgical device technology
Browse related patent infringement actions involving surgical access devices and trocar technology filed in the Ohio Northern District Court and comparable federal venues.
What this case signals for the surgical device IP landscape
A rapid settlement in a trocar patent case points to live enforcement risk in minimally invasive surgical access technology.
US11406806B2 remains an active enforcement asset after settlement
The case closed with prejudice against Bonds Therapeutics, but the patent itself is untouched. Vitalte retains the right to assert US11406806B2 against other parties. Companies designing or commercialising atraumatic trocar apparatus, systems, or kits should assess their FTO position against this patent now.
165-day resolution is a benchmark for surgical access device disputes in Ohio ND
Cases before Judge Gwin in the Northern District of Ohio that involve medical device patents can resolve quickly if parties have commercial incentive to settle early. Defendants in this court should anticipate rapid scheduling and budget for early-stage settlement evaluation alongside merits defence preparation.
Vitalte v Bonds — key questions answered
The case settled. The Ohio Northern District Court marked the docket 'settled and dismissed with prejudice' after counsel represented that the parties had reached a settlement. The court retained jurisdiction to resolve any disputes concerning memorialization of the agreement. The specific commercial terms of the settlement are not disclosed in the available public record.
Vitalte Lifesciences asserted US11406806B2, filed under application number US15/901821. The patent covers an atraumatic trocar apparatus, system and kit — a surgical access device designed to reduce tissue trauma during minimally invasive procedures.
Under Kokkonen v. Guardian Life Ins. Co., 511 U.S. 375 (1994), a federal court that expressly retains jurisdiction over a settlement agreement can enforce that agreement if a party later breaches it. In this case, the court's retention of jurisdiction indicates the parties had not fully memorialized their settlement in writing at the time of dismissal, and the court positioned itself to resolve any subsequent disputes over the agreement's terms.
The case was filed on 28 April 2023 and closed on 10 October 2023 — a duration of 165 days. This is a notably rapid resolution for a district-level patent infringement action, suggesting the parties reached settlement before significant pre-trial proceedings such as claim construction or summary judgment motion practice.
No. The settlement did not involve any merits adjudication of infringement or validity. The court made no finding on whether US11406806B2 was valid or infringed. The patent remains in force and enforceable against other parties. The dismissal with prejudice applies only to Vitalte's claims against Bonds Therapeutics in this specific proceeding.
This page is compiled from public court dockets and third-party patent and litigation data via PatSnap Eureka, and is provided for general informational purposes only. The information shown — including party names, patent and application numbers, dates, case status, outcomes, and any analysis — may be incomplete, may not reflect the most recent filings or legal status, and may contain errors or omissions. Verify all details against official court records (for example, PACER) and the relevant patent office before relying on them.
Nothing on this page constitutes legal advice or a legal opinion on the validity, infringement, enforceability, or scope of any patent or case, and no attorney‑client relationship is created by its use. Any description of an outcome (such as a dismissal, settlement, or consent judgment) is a general summary, not a legal determination. All patents, trademarks, and company or law‑firm names are the property of their respective owners. PatSnap makes no warranty as to the accuracy or completeness of this content and disclaims, to the fullest extent permitted by law, all liability for reliance on it. For advice on a specific matter, consult qualified legal counsel.
PatSnap Eureka searches patents and litigation data to answer instantly.